MicroRNA biosensors for detection of glioblastoma.
Biomarker
Cancer
Diagnosis
microRNA
Journal
Clinica chimica acta; international journal of clinical chemistry
ISSN: 1873-3492
Titre abrégé: Clin Chim Acta
Pays: Netherlands
ID NLM: 1302422
Informations de publication
Date de publication:
15 Mar 2024
15 Mar 2024
Historique:
received:
10
12
2023
revised:
10
02
2024
accepted:
11
02
2024
medline:
18
3
2024
pubmed:
15
2
2024
entrez:
14
2
2024
Statut:
ppublish
Résumé
Glioblastoma (GBM) is the most common type of malignant brain tumor.The discovery of microRNAs and their unique properties have made them suitable tools as biomarkers for cancer diagnosis, prognosis, and evaluation of therapeutic response using different types of nanomaterials as sensitive and specific biosensors. In this review, we discuss microRNA-based electrochemical biosensing systems and the use of nanoparticles in the evolving development of microRNA-based biosensors in glioblastoma.
Identifiants
pubmed: 38355000
pii: S0009-8981(24)00070-6
doi: 10.1016/j.cca.2024.117829
pii:
doi:
Substances chimiques
MicroRNAs
0
Biomarkers, Tumor
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
117829Informations de copyright
Copyright © 2024 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.